iShares Evolved U.S. Innovative Healthcare ETF

Yield per half year: 0%
Industry: Health & Biotech Equities

Johnson & Johnson
AbbVie
Merck & Co
Bristol-Myers
Vertex
Moderna
Amgen
Regeneron
Gilead Sciences
Alnylam Pharmaceuticals, Inc.
Zoetis
Biogen
Seagen
BioMarin Pharmaceutical
Other
Johnson & Johnson: 9.4%AbbVie: 5.9%Merck & Co: 5.7%Bristol-Myers: 5.3%Vertex: 5.2%Moderna: 4.4%Amgen: 4.3%Regeneron: 4.2%Gilead Sciences: 4.1%Other: 41.5%Share share by companyen.porti.ru
Download SVG
Download PNG
Download CSV
TitleIndustryShare, %P/BVP/SP/EEV/EbitdaDividend yield
Johnson & Johnson Johnson & Johnson Healthcare 9.42 5.79 4.67 11.32 13.82 3.1
AbbVie AbbVie Healthcare 5.87 26.42 5.06 56.49 17.75 3.31
Merck & Co Merck & Co Healthcare 5.71 7.29 4.56 751.54 40.3 2.82
Bristol-Myers Bristol-Myers Healthcare 5.33 3.69 2.41 13.54 7.23 4.56
Vertex Vertex Healthcare 5.23 6 10.73 29.17 24.42 0
Moderna Moderna Healthcare 4.38 2.68 4.93 8.96 -11.06 0
Amgen Amgen Healthcare 4.27 24.53 5.42 22.76 26.16 2.92
Regeneron Regeneron Healthcare 4.16 3.71 7.34 24.35 23.78 0.1388
Gilead Sciences Gilead Sciences Healthcare 4.1 4.41 3.7 17.69 15.66 3.69
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Healthcare 2.36 -108.14 13.05 0 -112.79 0
Zoetis Zoetis Healthcare 2.32 18.06 10.55 38.45 26.66 1.01
Biogen Biogen Healthcare 2.29 2.54 2.26 13.43 16.87 0
Seagen Seagen Healthcare 1.68 8.37 11.95 52.95 -37.17 0
BioMarin Pharmaceutical BioMarin Pharmaceutical Healthcare 1.35 3.72 4.51 30.16 71.81 0
58.470.656.5176.498.821.54

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription